1. Home
  2. NAMS vs NMRK Comparison

NAMS vs NMRK Comparison

Compare NAMS & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • NMRK
  • Stock Information
  • Founded
  • NAMS 2019
  • NMRK 1929
  • Country
  • NAMS Netherlands
  • NMRK United States
  • Employees
  • NAMS N/A
  • NMRK N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • NMRK Real Estate
  • Sector
  • NAMS Health Care
  • NMRK Finance
  • Exchange
  • NAMS Nasdaq
  • NMRK Nasdaq
  • Market Cap
  • NAMS 3.1B
  • NMRK 3.4B
  • IPO Year
  • NAMS N/A
  • NMRK 2017
  • Fundamental
  • Price
  • NAMS $32.86
  • NMRK $16.94
  • Analyst Decision
  • NAMS Strong Buy
  • NMRK Strong Buy
  • Analyst Count
  • NAMS 9
  • NMRK 5
  • Target Price
  • NAMS $41.89
  • NMRK $17.50
  • AVG Volume (30 Days)
  • NAMS 974.1K
  • NMRK 1.4M
  • Earning Date
  • NAMS 11-05-2025
  • NMRK 10-30-2025
  • Dividend Yield
  • NAMS N/A
  • NMRK 0.71%
  • EPS Growth
  • NAMS N/A
  • NMRK 44.43
  • EPS
  • NAMS N/A
  • NMRK 0.36
  • Revenue
  • NAMS $64,006,000.00
  • NMRK $2,983,234,000.00
  • Revenue This Year
  • NAMS N/A
  • NMRK $17.66
  • Revenue Next Year
  • NAMS $1.67
  • NMRK $9.19
  • P/E Ratio
  • NAMS N/A
  • NMRK $46.98
  • Revenue Growth
  • NAMS 762.15
  • NMRK 17.28
  • 52 Week Low
  • NAMS $14.06
  • NMRK $9.65
  • 52 Week High
  • NAMS $34.62
  • NMRK $19.78
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 72.18
  • NMRK 37.17
  • Support Level
  • NAMS $27.15
  • NMRK $18.02
  • Resistance Level
  • NAMS $34.59
  • NMRK $18.45
  • Average True Range (ATR)
  • NAMS 1.47
  • NMRK 0.45
  • MACD
  • NAMS 0.50
  • NMRK -0.33
  • Stochastic Oscillator
  • NAMS 73.37
  • NMRK 0.00

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About NMRK Newmark Group Inc.

Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.

Share on Social Networks: